Login / Signup

Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models.

Kristin StirmPeter LearyDaria WüstDominique StarkNicole JollerUfuk KarakusOnur BoymanAlexandar TzankovAnne Müller
Published in: Journal for immunotherapy of cancer (2023)
The combined data implicate Tregs as a potential therapeutic target in DLBCL, especially in combination with other immunotherapies.
Keyphrases
  • diffuse large b cell lymphoma
  • electronic health record
  • big data
  • human health
  • nk cells
  • risk assessment
  • machine learning
  • artificial intelligence